FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 307:397-400 August 12, 1982 Number 7 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Occasional reports have suggested that infants with congenital heart disease may have an increased risk of severe illness from respiratory syncytial virus (RSV) infection. We prospectively studied 699 infants hospitalized during the winters of 1976 through 1980, when RSV was prevalent in the community; 229 of these infants had proved RSV infections acquired either before admission or during hospitalization; 27 had both congenital heart disease and RSV infection, and 46 had congenital heart disease without RSV infection. Infected infants with congenital heart disease had significantly more severe illness than those without congenital heart disease, as judged by the requirement for intensive care and assisted ventilation and by the mortality rate (37 per cent vs. 1.5 per cent, P less than 0.01). The infection was acquired nosocomially by 21 per cent of infected infants; the mortality rate from nosocomial infection was also higher in infants with congenital heart disease (44 per cent vs. 5 per cent, P less than 0.01). Pulmonary hypertension was the one condition particularly associated with severe RSV illness. Eight of the 11 infants (73 per cent) with congenital heart disease and pulmonary hypertension died during their RSV illness. The courses in infants with congenital heart disease with and without RSV infection were also compared. Their ages, types of cardiac lesions, and incidence of pulmonary hypertension were similar, but the infants with RSV infection had a higher mortality rate (37 per cent vs. 6.5 per cent, P less than 0.1).

This article has been cited by other articles:

• Checchia, P. (2008). Identification and management of severe respiratory syncytial virus. Am J Health Syst Pharm 65: S7-S12 [Abstract] [Full Text]  
• Yanney, M, Vyas, H (2008). The treatment of bronchiolitis. Arch. Dis. Child. 93: 793-798 [Abstract] [Full Text]  
• Mansbach, J. M., Clark, S., Christopher, N. C., LoVecchio, F., Kunz, S., Acholonu, U., Camargo, C. A. Jr (2008). Prospective Multicenter Study of Bronchiolitis: Predicting Safe Discharges From the Emergency Department. Pediatrics 121: 680-688 [Abstract] [Full Text]  
• Bloemers, B. L.P., van Furth, A. M., Weijerman, M. E., Gemke, R. J.B.J., Broers, C. J.M., van den Ende, K., Kimpen, J. L.L., Strengers, J. L.M., Bont, L. J. (2007). Down Syndrome: A Novel Risk Factor for Respiratory Syncytial Virus Bronchiolitis A Prospective Birth-Cohort Study. Pediatrics 120: e1076-e1081 [Abstract] [Full Text]  
• Howidi, M., Rajah, J., Abushrar, Z., Parsons, H. (2007). The Severity of Respiratory Syncytial Virus Bronchiolitis in Young Infants in the United Arab Emirates. J Trop Pediatr 53: 22-26 [Abstract] [Full Text]  
• Zhao, X., Liu, E., Chen, F.-P., Sullender, W. M. (2006). In Vitro and In Vivo Fitness of Respiratory Syncytial Virus Monoclonal Antibody Escape Mutants. J. Virol. 80: 11651-11657 [Abstract] [Full Text]  
• Stensballe, L. G., Kristensen, K., Simoes, E. A.F., Jensen, H., Nielsen, J., Benn, C. S., Aaby, P., for the Danish RSV Data Network, (2006). Atopic Disposition, Wheezing, and Subsequent Respiratory Syncytial Virus Hospitalization in Danish Children Younger Than 18 Months: A Nested Case-Control Study. Pediatrics 118: e1360-e1368 [Abstract] [Full Text]  
• Subcommittee on Diagnosis and Management of Bronch, (2006). Diagnosis and Management of Bronchiolitis. Pediatrics 118: 1774-1793 [Abstract] [Full Text]  
• Thorburn, K, Harigopal, S, Reddy, V, Taylor, N, van Saene, H K F (2006). High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61: 611-615 [Abstract] [Full Text]  
• Choudhuri, J. A., Ogden, L. G., Ruttenber, A. J., Thomas, D. S.K., Todd, J. K., Simoes, E. A.F. (2006). Effect of Altitude on Hospitalizations for Respiratory Syncytial Virus Infection. Pediatrics 117: 349-356 [Abstract] [Full Text]  
• Choudhary, S., Boldogh, S., Garofalo, R., Jamaluddin, M., Brasier, A. R. (2005). Respiratory Syncytial Virus Influences NF-{kappa}B-Dependent Gene Expression through a Novel Pathway Involving MAP3K14/NIK Expression and Nuclear Complex Formation with NF-{kappa}B2. J. Virol. 79: 8948-8959 [Abstract] [Full Text]  
• Leidy, N. K., Margolis, M. K., Marcin, J. P., Flynn, J. A., Frankel, L. R., Johnson, S., Langkamp, D., Simoes, E. A. F. (2005). The Impact of Severe Respiratory Syncytial Virus on the Child, Caregiver, and Family During Hospitalization and Recovery. Pediatrics 115: 1536-1546 [Abstract] [Full Text]  
• Yount, L. E., Mahle, W. T. (2004). Economic Analysis of Palivizumab in Infants With Congenital Heart Disease. Pediatrics 114: 1606-1611 [Abstract] [Full Text]  
• Brasier, A. R., Spratt, H., Wu, Z., Boldogh, I., Zhang, Y., Garofalo, R. P., Casola, A., Pashmi, J., Haag, A., Luxon, B., Kurosky, A. (2004). Nuclear Heat Shock Response and Novel Nuclear Domain 10 Reorganization in Respiratory Syncytial Virus-Infected A549 Cells Identified by High-Resolution Two-Dimensional Gel Electrophoresis. J. Virol. 78: 11461-11476 [Abstract] [Full Text]  
• Duppenthaler, A, Ammann, R A, Gorgievski-Hrisoho, M, Pfammatter, J-P, Aebi, C (2004). Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease. Arch. Dis. Child. 89: 961-965 [Abstract] [Full Text]  
• Bloomfield, P, Dalton, D, Karleka, A, Kesson, A, Duncan, G, Isaacs, D (2004). Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch. Dis. Child. 89: 363-367 [Abstract] [Full Text]  
• Zhang, Y., Jamaluddin, M., Wang, S., Tian, B., Garofalo, R. P., Casola, A., Brasier, A. R. (2003). Ribavirin Treatment Up-Regulates Antiviral Gene Expression via the Interferon-Stimulated Response Element in Respiratory Syncytial Virus-Infected Epithelial Cells. J. Virol. 77: 5933-5947 [Abstract] [Full Text]  
• Viuff, B., Tjornehoj, K., Larsen, L. E., Rontved, C. M., Uttenthal, A., Ronsholt, L., Alexandersen, S. (2002). Replication and Clearance of Respiratory Syncytial Virus: Apoptosis Is an Important Pathway of Virus Clearance after Experimental Infection with Bovine Respiratory Syncytial Virus. Am. J. Pathol. 161: 2195-2207 [Abstract] [Full Text]  
• Kamal-Bahl, S., Doshi, J., Campbell, J. (2002). Economic Analyses of Respiratory Syncytial Virus Immunoprophylaxis in High-Risk Infants: A Systematic Review. Arch Pediatr Adolesc Med 156: 1034-1041 [Abstract] [Full Text]  
• Johnson, D. W., Adair, C., Brant, R., Holmwood, J., Mitchell, I. (2002). Differences in Admission Rates of Children With Bronchiolitis by Pediatric and General Emergency Departments. Pediatrics 110: e49-49 [Abstract] [Full Text]  
• Bockova, J., O'Brien, K. L., Oski, J., Croll, J., Reid, R., Weatherholtz, R. C., Santosham, M., Karron, R. A. (2002). Respiratory Syncytial Virus Infection in Navajo and White Mountain Apache Children. Pediatrics 110: e20-20 [Abstract] [Full Text]  
• Jones, L. P., Zheng, H.-Q., Karron, R. A., Peret, T. C. T., Tsou, C., Anderson, L. J. (2002). Multiplex Assay for Detection of Strain-Specific Antibodies against the Two Variable Regions of the G Protein of Respiratory Syncytial Virus. CVI 9: 633-638 [Abstract] [Full Text]  
• Kahn, J. S., Roberts, A., Weibel, C., Buonocore, L., Rose, J. K. (2001). Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge. J. Virol. 75: 11079-11087 [Abstract] [Full Text]  
• Carlsen, K-;H., Sterk, P.J. (2001). Infection: friend or foe to the development of asthma?. Eur Respir J 18: 744-747 [Full Text]  
• Zhang, Y., Luxon, B. A., Casola, A., Garofalo, R. P., Jamaluddin, M., Brasier, A. R. (2001). Expression of Respiratory Syncytial Virus-Induced Chemokine Gene Networks in Lower Airway Epithelial Cells Revealed by cDNA Microarrays. J. Virol. 75: 9044-9058 [Abstract] [Full Text]  
• Casola, A., Garofalo, R. P., Haeberle, H., Elliott, T. F., Lin, R., Jamaluddin, M., Brasier, A. R. (2001). Multiple cis Regulatory Elements Control RANTES Promoter Activity in Alveolar Epithelial Cells Infected with Respiratory Syncytial Virus. J. Virol. 75: 6428-6439 [Abstract] [Full Text]  
• Brandenburg, A. H., van Beek, R., Moll, H. A., Osterhaus, A. D. M. E., Claas, E. C. J. (2000). G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity. J. Clin. Microbiol. 38: 3849-3852 [Abstract] [Full Text]  
• Owayed, A. F., Campbell, D. M., Wang, E. E. L. (2000). Underlying Causes of Recurrent Pneumonia in Children. Arch Pediatr Adolesc Med 154: 190-194 [Abstract] [Full Text]  
• Sudo, K., Watanabe, W., Konno, K., Sato, R., Kajiyashiki, T., Shigeta, S., Yokota, T. (1999). Efficacy of RD3-0028 Aerosol Treatment against Respiratory Syncytial Virus Infection in Immunosuppressed Mice. Antimicrob. Agents Chemother. 43: 752-757 [Abstract] [Full Text]  
• MOLER, F. W., OHMIT, S. E. (1999). Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization. Am. J. Respir. Crit. Care Med. 159: 1234-1240 [Abstract] [Full Text]  
• Committee on Infectious Diseases and Committee on, (1998). Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV. Pediatrics 102: 1211-1216 [Abstract] [Full Text]  
• Dudas, R. A., Karron, R. A. (1998). Respiratory Syncytial Virus Vaccines. Clin. Microbiol. Rev. 11: 430-439 [Abstract] [Full Text]  
• Jamaluddin, M., Casola, A., Garofalo, R. P., Han, Y., Elliott, T., Ogra, P. L., Brasier, A. R. (1998). The Major Component of Ikappa Balpha Proteolysis Occurs Independently of the Proteasome Pathway in Respiratory Syncytial Virus-Infected Pulmonary Epithelial Cells. J. Virol. 72: 4849-4857 [Abstract] [Full Text]  
• Nachman, S. A., Navaie-Waliser, M., Qureshi, M. Z. (1997). Rehospitalization With Respiratory Syncytial Virus After Neonatal Intensive Care Unit Discharge: A 3-Year Follow-up. Pediatrics 100: e8-e8 [Abstract] [Full Text]  
• Rodriguez, W. J., Gruber, W. C., Groothuis, J. R., Simoes, E. A. F., Rosas, A. J., Lepow, M., , A. K., Hemming, V., the RSV-IGIV Study Group, (1997). Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children. Pediatrics 100: 937-942 [Abstract] [Full Text]  
• Langley, J. M., LeBlanc, J. C., Wang, E. E. L., Law, B. J., MacDonald, N. E., Mitchell, I., Stephens, D., McDonald, J., Boucher, F. D., Dobson, S. (1997). Nosocomial Respiratory Syncytial Virus Infection in Canadian Pediatric Hospitals: A Pediatric Investigators Collaborative Network on Infections in Canada Study. Pediatrics 100: 943-946 [Abstract] [Full Text]  
• Brandenburg, A. H, Jeannet, P.-Y., Steensel-Moll, H. A v, Ott, A., Rothbarth, P. H, Wunderli, W., Suter, S., Neijens, H. J, Osterhaus, A. D M E, Siegrist, C.-A. (1997). Local variability in respiratory syncytial virus disease severity. Arch. Dis. Child. 77: 410-414 [Abstract] [Full Text]  
• Meissner, H. C., Groothuis, J. R. (1997). Immunoprophylaxis and the Control of RSV Disease. Pediatrics 100: 260-260 [Full Text]  
• Committee on Infectious Diseases, , Committee on Fetus and Newborn, (1997). Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use. Pediatrics 99: 645-650 [Abstract] [Full Text]  
• Rodriguez, W. J., Gruber, W. C., Welliver, R. C., Groothuis, J. R., Simoes, E. A. F., Meissner, H. C., Hemming, V. G., Hall, C. B., Lepow, M. L., Rosas, A. J., Robertsen, C., Kramer, A. A. (1997). Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections. Pediatrics 99: 454-461 [Abstract] [Full Text]  
• Fisher, R. G., Gruber, W. C., Edwards, K. M., Reed, G. W., Tollefson, S. J., Thompson, J. M., Wright, P. F. (1997). Twenty Years of Outpatient Respiratory Syncytial Virus Infection: A Framework for Vaccine Efficacy Trials. Pediatrics 99: e7-e7 [Abstract] [Full Text]  
• The PREVENT Study Group, (1997). Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis. Pediatrics 99: 93-99 [Abstract] [Full Text]  
• Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., Tristram, D. A., Siber, G. R., Prince, G. A., Van Raden, M., Hemming, V. G., The Respiratory Syncytial Virus Immune Globulin St, (1993). Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children. NEJM 329: 1524-1530 [Abstract] [Full Text]  
• McIntosh, K. (1993). Respiratory Syncytial Virus -- Successful Immunoprophylaxis at Last. NEJM 329: 1572-1574 [Full Text]  
• La Via, W. V., Grant, S. W., Stutman, H. R., Marks, M. I. (1993). Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection. CLIN PEDIATR 32: 450-454 [Abstract]  
• Njoku, D. B., Kliegman, R. M. (1993). Atypical Extrapulmonary Presentations Of Severe Respiratory Syncytial Virus Infection Requiring Intensive Care. CLIN PEDIATR 32: 455-460 [Abstract]  
• Friedman, A. D., Naqvi, S. H., Arens, M. Q., Eyler, M. A. (1986). Value of Rapid Diagnosis of Respiratory Syncytial Virus Infection on Management of Small Infants. CLIN PEDIATR 25: 404-406 [Abstract]